Gluvilda D, Dapagliflozin/ Vildagliptin

Dapagliflozin is used in the treatment of type 2 diabetes which helps to control the amount of sugar in the blood.

Dapagliflozin is known as a sodium-glucose cotransporter 2 (SGLT2) inhibitor. Dapagliflozin reduces the levels of sugar the body absorbs and increases the levels of sugar that leaves the body in the urine, however Dapagliflozin should be used together with regular exercise and the control of diet.

Patients who take Dapagliflozin may suffer from such side effects;

Nausea,
Frequent urge to urinate,
Increased thirst,
Urinary tract infection,
Symptoms of hypoglycaemia: feeling shaky or anxious,
Sweating,
Looking pale,
Feeling hungry,
Feeling that your heart is pounding (palpitations),
Feeling dizzy
Hypoglycaemia (Low blood sugar level) in combination with insulin or sulphonylurea,
Genital fungal infection

Vildagliptin　is used in the treatment of type 2 diabetes mellitus which is also known as non-insulin-dependent diabetes (NIDDM)

Vildagliptin works in treatment of diabetes by increasing the amount of insulin produced by the body. Insulin helps control the level of sugar in the blood. Vildagliptin also reduces the amount of glucagon being produced by the pancreas, Glucagon causes your liver to produce more sugar, thus by reducing the amount of glucagon in the body by using Vildagliptin, this also helps to reduce the levels of sugar in the blood directly. Vildagliptin is used together with a good diet and also exercise.

Patients who take Vildagliptin may suffer from such side effects;

Headaches,
Hypoglycaemia (Low blood sugar level),
Nasopharyngitis,
Upper respiratory tract infection,
Cold sweats,
Changes in heart rate,
Palpitations,
Severe hunger,
Shaking,
Confusion,
Difficulty concentrating,
Mood changes